MRK News

Veterinary Vaccines Market Forecast 2026-2036: Industry to Reach USD 18.2 Billion by 2036 at 5.4% CAGR

50/50 Women on Boards™ to Open 2026 Global Summit with The Breakfast of Corporate Champions

Global Respiratory Syncytial Virus (RSV) Vaccines Market to Reach $1.24 Billion by 2030 | MarketsandMarkets™

3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More

Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons

Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ Drugs - Collaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech

PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 200+ Drugs from Over 180 Companies by Company, Product Type, Stage, Route of Administration, and Molecule Type

Atopic Dermatitis Competitive Landscape Report 2026: Comprehensive Insights About 100+ Companies and 110+ Drugs

Autogenous Vaccines Market to Reach US$ 451.5 Million by 2033; Expands Amid Rising Livestock Health Needs and Precision Disease Control - Persistence Market Research